Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
The report was co-authored with EDP and Nestlé and released by the World Business Council for Sustainable Development (WBCSD).
This report builds on WBCS D’s Corporate Renewable Power Purchase Agreements: Scaling up globally report (October 2016), which provides background on corporate power purchase agreements (PPAs). The initial report includes the opportunities that PPAs offer, the obstacles corporate buyers and developers face as they plan and negotiate PPAs and potential solutions to challenges.
The objective of this Innovation in Power Purchase Agreement (PPA) Structures report is to identify further challenges that corporate buyers have come across as the corporate PPA market has grown and evolved in existing and new markets and jurisdictions. It identifies examples of innovations in different markets as a result.
Our hope is that better understanding of these challenges and innovations will accelerate deployment of more corporate PPAs in mature markets and that it will also assist in the development of successful new markets for corporate PPAs. In each case, though, innovations in one market may not be applicable in other markets due to different market dynamics.
Recent publications
Publication
African nations need to present a united front at COP29 to ensure their voices are heard
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .